Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Tearlab Corporation (NASDAQ: TEAR)

$2.00 USD -$0.05 (-2.44%)
Last Price $2
Net Change $-0.05 (-2.44%)
Bid $2
Ask Price $2.02
Open Price $2.02
Previous Close Price $2.05
High Price $2.09
Low Price $2
Number of Trades 184
Volume 68,525
Fifty Two Week High $9 (2016-08-01)
Fifty Two Week Low $1.85 (2017-04-06)
Average Daily Volume 116,079
Share Outstanding 5,740 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.82 (2017-05-15)
2nd Quarter Earnings $-0.81 (2017-03-09)
3nd Quarter Earnings $-0.7 (2016-11-07)
4th Quarter Earnings $-0.8 (2016-08-03)
PE Ratio $0
EPS Growth $35.9
Recent Earnings $-0.82
Annual EPS $-3.33
Last Quarter EPS $
Market Capitalization $0.01B
Insider Shareholders % 0.116%
Annual Revenue $0B
No. Shares Outstanding 5,740
Inst. Shareholder % 27.25%
Annual Net Income $-0.02B
TTM Net Profit Margin $-61.13
1-Year Return -73.72%
3-Year Return -95.75%
5-Year Return -93.47%
5-Year Revenue Growth 1221.23%
5-Year Earnings Growth 22.57%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 35.900002%
Dividends per Share $
Stock Split Ratio 1-10
Beta 2.54
TearLab Corporation is an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. The Company is commercializing a proprietary in vitro diagnostic tear testing platform, the TearLabTM Osmolarity System, which is capable of accurately and rapidly measuring biomarkers in tears at the point-of-care. The TearLabTM System requires nanoliters of tears for testing, potentially reducing collection time and simplifying the tear collection process. TearLab Corporation, formerly known as OccuLogix Inc., is headquartered in San Diego, California.

No News found for TEAR